Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients (original) (raw)

References

  1. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO Multinational Study of vascular diseases in diabetes. Diabetologia 44:S14–S21
    Article PubMed Google Scholar
  2. Hammoud T, Tanguay JF, Bourassa MG (2000) Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol 36:355–365
    Article PubMed CAS Google Scholar
  3. Gazzaruso C (2005) Erectile dysfunction and silent myocardial ischemia. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds) Harrison’s Principles of internal medicine, 16th edn. McGraw Hill Medical, New York, NY (1/13/2005 update online)
  4. Koistinen MJ (1990) Prevalence of asymptomatic myocardial ischemia in diabetic subjects. BMJ 301:92–95
    Article PubMed CAS Google Scholar
  5. Lorusso R, Pentiricci S, Raddino R, Scarabelli TM, Zambelli C, Villanacci V, Burattin A, Romalelli G, Casari S, Scelsi R, Giustina A (2003) Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. Diabetes 52:2814–2820
    Article PubMed CAS Google Scholar
  6. Jouven X, Lemaitre RN, Rea TD, Sotoodehnia N, Empana JP, Siscovick DS (2005) Diabetes, glucose level, and risk of sudden cardiac death. Eur Heart J 26:2142–2147
    Article PubMed Google Scholar
  7. Huxley R, Barzi F, Woodward M (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332:73–78
    Article PubMed Google Scholar
  8. Smith JW, Marcus FI, Serokman R (1984) Prognosis of patients with diabetes mellitus after acute myocardial infarction. Am J Cardiol 54:718–721
    Article PubMed CAS Google Scholar
  9. Adult treatment panel III (2001) Executive summary of the third report of the national cholesterol education program (NCEP) Expert panel of detection evaluation, and treatment of high blood cholesterol in adults. JAMA 285:2486–2497
    Article Google Scholar
  10. Haffner SM, Lehto S, Ronnemaa T (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234
    Article PubMed CAS Google Scholar
  11. Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ, Hansen ML, Folke F, Buch P, Madsen M, Vaag A, Torp-Pedersen C (2008) Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 117:1945–1954
    Article PubMed CAS Google Scholar
  12. American Diabetes Association (1998) Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 21:1551–1559
    Google Scholar
  13. Bax JJ, Young LH, Frye RL, Bonow RO, Steinberg HO, Barrett EJ, For the American Diabetes Association (2007) Screening for coronary artery disease in patients with diabetes. Diabetes Care 30:2729–2736
    Article PubMed Google Scholar
  14. Gibbsons RJ (2006) Asymptomatic patients with diabetes mellitus should not be screened for coronary artery disease. J Nucl Cardiol 13:616–620
    Article Google Scholar
  15. Wackers FJT (2006) Asymptomatic patients with diabetes mellitus should be screened for coronary artery disease. J Nucl Cardiol 13:609–615
    Article PubMed Google Scholar
  16. Miller TD, Redberg RF, Wackers FJT (2006) Screening asymptomatic diabetic patients for coronary artery disease. Why not? J Am Coll Cardiol 48:761–764
    Article PubMed Google Scholar
  17. Beller GA (2007) Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic type 2 diabetic patients. Is it appropriate and cost-effective? J Am Coll Cardiol 49:1918–1923
    Article PubMed Google Scholar
  18. Faglia E, Mantero M, Quarantiello A, Gino M, Curci V, Caminiti M, Mattioli R, Morabito A (2005) Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. Am Heart J 149:e1–e6
    Article PubMed Google Scholar
  19. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Heller GV, Iskandrian AE, Wittlin SD, Filipchuk N, Ratner RE, Inzucchi SE, DIAD Investigators (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. The DIAD study: a randomized controlled trial. JAMA 301:1547–1555
    Article PubMed CAS Google Scholar
  20. Cohn PF (1988) Silent myocardial ischemia. Ann Intern Med 109:312–317
    PubMed CAS Google Scholar
  21. Gazzaruso C, Solerte SB, Pujia A, Coppola A, Vezzoli M, Salvucci F, Valenti C, Giustina A, Garzaniti A (2008) Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with asymptomatic coronary artery disease angiographically proven. A potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol 51:2040–2044
    Article PubMed Google Scholar
  22. Gazzaruso C, Pujia A, Solerte SB, Amici ED, Emanuele E, Falcone C, Geroldi D, Giustina A, Garzaniti A (2006) Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients. Int J Impot Res 18:311–315
    Article PubMed CAS Google Scholar
  23. The Expert Committee on the diagnosis and classification of diabetes mellitus (1997) Report of the Expert Committee on the Diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
    Google Scholar
  24. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A; ESH-ESC Task Force on the Management of Arterial Hypertension (2007) ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25(9):1751–1762
  25. Giustina A, Perini P, Desenzani P, Bossoni S, Ianniello P, Milani M, Davì G, Romanelli G (1998) Long-term treatment with the dual antithrombotic agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients. Diabetes 47:423–430
    Article PubMed CAS Google Scholar
  26. Gazzaruso C, Garzaniti A, Giordanetti S, Falcone C, Fratino P (2002) Silent coronary artery disease in type 2 diabetes mellitus: the role of lipoprotein(a), homocysteine and apo(a) polymorphism. Cardiovasc Diabetol 1:5
    Article PubMed Google Scholar
  27. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502
    PubMed CAS Google Scholar
  28. Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, Fratino P, Solerte SB, Garzaniti A (2004) Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 110:22–26
    Article PubMed Google Scholar
  29. Gazzaruso C, Solerte SB, De Amici E, Mancini M, Pujia A, Fratino P, Giustina A, Garzaniti A (2006) Association of the metabolic syndrome and insulin-resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus. Am J Cardiol 97:236–239
    Article PubMed CAS Google Scholar
  30. Choi EK, Koo BK, Kim HS, Cho YM, Kang HJ, Cho YS, Chung WY, Chae IH, Choi DJ, Oh BH, Park YB, Choi YS (2007) Prognostic significance of asymptomatic coronary artery disease in patients with diabetes and need for early revascularization therapy. Diab Med 24:1003–1011
    Google Scholar
  31. Chaitman BR, Hardison RM, Adler D, Gebhart S, Grogan M, Ocampo S, Sopko G, Ramires JA, Schneider D, Frye RL, Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study Group (2009) The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 120:2529–2540
    Article PubMed CAS Google Scholar
  32. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association, National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Statement. Circulation 112:2735–2752
    Article PubMed Google Scholar
  33. Martin JH, Mangiafico S, Kelly DJ (2009) Role of statins in diabetes complications. Curr Diab Rev 5:165–170
    Article CAS Google Scholar
  34. Albers AR, Krichavsky MZ, Balady GJ (2006) Stress testing in patients with diabetes. Diagnostic and prognostic value. Circulation 113:583–592
    Article PubMed Google Scholar
  35. Barthelemy O, Le Fevre C, Timsit J (2007) Silent myocardial ischemia screening in patients with diabetes mellitus. Arq Bras Endocrinol Metab 51(/2):285–293
    Google Scholar
  36. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, Taillefer R, Wittlin SD, Heller GV, Filipchuk N, Engel S, Ratner RE, Iskandrian AE, Detection of Ischemia in Asymptomatic Diabetics Investigators (2004) Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27:1954–1961
    Article PubMed Google Scholar
  37. Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A (2006) Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 47:65–71
    Article PubMed Google Scholar
  38. Poulsen MK, Henriksen JE, Vach W, Dahl J, Møller JE, Johansen A, Gerke O, Haghfelt T, Høilund-Carlsen PF, Beck-Nielsen H (2010) Identification of asymptomatic type 2 diabetes mellitus patients with a low, intermediate and high risk of ischemic heart disease: is there an algorithm? Diabetologia 53:659–667
    Google Scholar
  39. Turrini F, Messora R, Giovanardi P, Tondi S, Magnavacchi P, Cavani R, Tosoni G, Cappelli C, Pellegrini E, Romano S, Baldini A, Zennaro RG, Bondi M (2009) Screening asymptomatic patients with diabetes for unknown coronary artery disease: does it reduce risk? An open-label randomized trial comparing a strategy based on exercise testing aimed at revascularization with management based on pharmacological/behavioural treatment of traditional risk factors. DADDY-D trial (Does coronary Atherosclerosis Deserve to be Diagnosed and treated early in Diabetics?). Trial 10:119
    Article Google Scholar

Download references